Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: W-L-Z (I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein W, L and Z are defined herein.

 
Web www.patentalert.com

< Gastric treatment/diagnosis device and attachment device and method

> Method and devices for stimulation of an organ with the use of a transectionally placed guide wire

> Triazolopyridine cannabinoid receptor 1 antagonists

~ 00537